REGENXBIO Reports Positive Biomarker Data from the AFFINITY DUCHENNE ®Trial of RGX-202 Gene Therapy
“RGX-202 is the only next generation gene therapy for Duchenne [...]
Science behind “Polly Want a Cracker” Could Guide Future Treatment Design for Speech Disorders
Published online March 19 in the journal Nature, the study [...]
Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025
Vidofludimus Calcium’s Activation of Nurr1 reduces neuronal loss and injury [...]
Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
The Audiogene trial is designed to evaluate the safety, tolerability [...]
New Clinical Trial Regulations Set to Speed up Medical Innovation
This article gives an overview of the new clinical trial [...]
Unveiling the Future of Neuropathy Treatment: NEUBIE Device Shows Remarkable Results
“Neuropathy is incredibly common among the aging population, regardless of [...]
Study Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making in the Evaluation for Alzheimer’s Disease
Dr. Joel Braunstein, CEO of C2N Diagnostics, says, “This research [...]
Key Considerations When Choosing an IRT System for Clinical Trials
Interactive Response Technology (IRT) helps clinical trial sites and sponsors [...]
NFL Alumni Joel Dreessen and Le-Lo Lang Team Up With HeartFlow and Boone Heart Institute to Launch GAMEFILM Registry to Assess Heart Disease Risks in Retired Football Players
The GAMEFILM Registry will enroll approximately 120 NFL alumni. The [...]
Neogap Therapeutics Reports First Patients Treated in Neogap Personalized Immunotherapy Trial
“We are delighted to have treated the first patients – [...]